Purple Biotech Q3 EPS $(0.23), Inline; $15.9M In Cash, Cash Equivalents And Short-term Deposits. In October 2023 The Company Raised An Additional Gross Amount Of $5M Extended The Cash Runway To The Second Half Of 2025
Benzinga Newsdesk - Nov 21, 2023, 6:56AM